phosphorylethanolamine has been researched along with Spinal Muscular Atrophies of Childhood in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Spinal Muscular Atrophies of Childhood: A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rochmah, MA | 1 |
| Wijaya, YOS | 1 |
| Harahap, NIF | 1 |
| Tode, C | 1 |
| Takeuchi, A | 1 |
| Ohuchi, K | 1 |
| Shimazawa, M | 1 |
| Hara, H | 1 |
| Funato, M | 1 |
| Saito, T | 1 |
| Saito, K | 1 |
| Lai, PS | 1 |
| Awano, H | 1 |
| Shinohara, M | 1 |
| Nishio, H | 1 |
| Niba, ETE | 1 |
1 other study available for phosphorylethanolamine and Spinal Muscular Atrophies of Childhood
| Article | Year |
|---|---|
Phosphoethanolamine Elevation in Plasma of Spinal Muscular Atrophy Type 1 Patients.
Topics: Animals; Biomarkers; Case-Control Studies; Child, Preschool; Ethanolamines; Gas Chromatography-Mass | 2020 |